Core Scientific (CORZ) Receivables - Other (2021 - 2023)

Core Scientific has disclosed Receivables - Other across 3 years of filings, most recently posting $2000.0 for Q1 2023.

• Receivables - Other for Q1 2023 came in at $2000.0, down 99.42% year-over-year; the trailing twelve-month figure through Mar 2023 was $2000.0 (down 99.42% YoY), and the FY2022 annual result was $23000.0, down 92.33% from the prior year.
• Receivables - Other came in at $2000.0 for Q1 2023 at Core Scientific, down from $23000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $895000.0 in Q3 2022 to a low of $2000.0 in Q1 2023.
• The 3-year median for Receivables - Other is $321000.0 (2021), against an average of $373166.7.
• Across the five-year window, Receivables - Other slumped 92.33% in 2022 and slumped 99.42% in 2023, its largest moves.
• Core Scientific's Receivables - Other stood at $300000.0 in 2021, then plunged by 92.33% to $23000.0 in 2022, then slumped by 91.3% to $2000.0 in 2023.
• The last three Receivables - Other figures came in at $2000.0 (Q1 2023), $23000.0 (Q4 2022), and $895000.0 (Q3 2022), per Business Quant data.